References
Adriani W, Rea M, et al. Acetyl-L-carnitine
reduces impulsive behaviour in adolescent rats. Psychopharmacology
(Berl). 2004 Nov;176(3-4):296-304.
Akhondzadeh S, Mohammadi MR, et al. Zinc sulfate as an adjunct to
methylphenidate for the treatment of attention deficit hyperactivity
disorder in children: a double blind and randomized trial
[ISRCTN64132371]. BMC Psychiatry. 2004 Apr 8;4:9.
Arnold LE, Bozzolo H, et al. Serum zinc correlates with parent- and
teacher- rated inattention in children with
attention-deficit/hyperactivity disorder. J Child Adolesc
Psychopharmacol. 2005a Aug;15(4):628-36.
Arnold LE, DiSilvestro RA. Zinc in attention-deficit/hyperactivity
disorder. J Child Adolesc Psychopharmacol. 2005b Aug;15(4):619-27.
Bandstra ES, Morrow CE, et al. Longitudinal investigation of task
persistence and sustained attention in children with prenatal cocaine
exposure. Neurotoxicol Teratol. 2001 Nov;23(6):545-59.
Barkley R. ADHD and the Nature of Self Control. New York, NY: Guilford; 1997: 136-42.
Betancourt-Fursow de Jiminez YM, Jiminez-Leon JC, et al. Attention
deficit hyperactivity disorder and sleep disorders [in Spanish]. Rev
Neurol. 2006 Feb 13;42(suppl 2):S37-S51.
Biederman J, Mick E, et al. Age-dependent decline of symptoms of
attention deficit hyperactivity disorder: impact of remission
definition and symptom type. Am J Psychiatry. 2000 May;157(5):816-8.
Bilici M, Yildirim F, et al. Double-blind, placebo-controlled study
of zinc sulfate in the treatment of attention deficit hyperactivity
disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004
Jan;28(1):181-90.
Boris M, Mandel FS. Foods and additives are common causes of the
attention deficit hyperactive disorder in children. Ann Allergy. 1994
May;72(5):462-8.
Chaves-Carballo E. Diet therapy in the treatment of neuropediatric
disorders [in Spanish]. Rev Neurol. 2003 Aug 1-15;37(3):267-74.
Christman AK, Fermo JD, et al. Atomoxetine, a novel treatment for
attention-deficit-hyperactivity disorder. Pharmacotherapy. 2004
Aug;24(8):1020-36.
Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325-41.
Davenport TH, Beck JC. Getting the attention you need. Harv Bus Rev. 2000 Sep;78(5):118-26, 200.
Daviss WB, Bentivoglio P, et al. Bupropion sustained release in
adolescents with comorbid attention-deficit/hyperactivity disorder and
depression. J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14.
Egger J, Carter CM, et al. Controlled trial of oligoantigenic
treatment in the hyperkinetic syndrome. Lancet. 1985 Mar
9;1(8428):540-5.
Girardi NL, Shaywitz SE, et al. Blunted catecholamine responses
after glucose ingestion in children with attention deficit disorder.
Pediatr Res. 1995 Oct;38(4):539-42.
Goddard J. Perceived passage of time: its possible relationship to
attention-deficit hyperactivity disorder. Med Hypotheses. 2000
Oct;55(4):351-2.
Haag M. Essential fatty acids and the brain. Can J Psychiatry. 2003 Apr;48(3):195-203.
Hamrin V, Bailey K. Gabapentin and methylphenidate treatment of a
preadolescent with attention deficit hyperactivity disorder and bipolar
disorder. J Child Adolesc Psychopharmacol. 2001;11(3):301-9.
Harding KL, Judah RD, et al. Outcome-based comparison of Ritalin
versus food-supplement treated children with AD/HD. Altern Med Rev.
2003 Aug;8(3):319-30.
Hartman CA, Willcutt EG, et al. The relation between sluggish
cognitive tempo and DSM-IV ADHD. J Abnorm Child Psychol. 2004
Oct;32(5):491-503.
Holtkamp K, Peters-Wallraf B, et al. Methylphenidate-related growth
impairment. J Child Adolesc Psychopharmacol. 2002 Spring;12(1):55-61.
Joshi K, Lad S, et al. Supplementation with flax oil and vitamin C
improves the outcome of Attention Deficit Hyperactivity Disorder
(ADHD). Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21.
Kasper DL, Braunwald E, et al, eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
Kelsey DK, Sumner CR, et al. Once-daily atomoxetine treatment for
children with attention-deficit/hyperactivity disorder, including an
assessment of evening and morning behavior: a double-blind,
placebo-controlled trial. Pediatrics. 2004 Jul;114(1):e1-e8.
Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in
children: rationale for its integrative management. Altern Med Rev.
2000 Oct;5(5):402-28.
Konofal E, Lecendreux M, et al. Iron deficiency in children with
attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med.
2004 Dec;158(12):1113-5.
Krummel DA, Seligson FH, et al. Hyperactivity: is candy causal? Crit Rev Food Sci Nutr. 1996 Jan;36(1-2):31-47.
Levin ED, Conners CK, et al. Effects of chronic nicotine and
methylphenidate in adults with attention deficit/hyperactivity
disorder. Exp Clin Psychopharmacol. 2001 Feb;9(1):83-90.
Lyon MR, Cline JC, et al. Effect of the herbal extract combination
Panax quinquefolium and Ginkgo biloba on attention-deficit
hyperactivity disorder: a pilot study. J Psychiatry Neurosci. 2001
May;26(3):221-8.
Maayan R, Yoran-Hegesh R, et al. Three-month treatment course of
methylphenidate increases plasma levels of dehydroepiandrosterone
(DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit
hyperactivity disorder. Neuropsychobiology. 2003;48(3):111-5.
Mercugliano M. What is attention-deficit/hyperactivity disorder? Pediatr Clin North Am. 1999 Oct;46(5):831-43.
Millichap JG, Yee MM, et al. Serum ferritin in children with
attention-deficit hyperactivity disorder. Pediatr Neurol. 2006
Mar;34(3):200-3.
Mitsis EM, Halperin JM, et al. Serotonin and aggression in children. Curr Psychiatry Rep. 2000 Apr;2(2):95-101.
Mousain-Bosc M, Roche M, et al. Magnesium VitB6 intake reduces
central nervous system hyperexcitability in children. J Am Coll Nutr.
2004 Oct;23(5):545S-548S.
National Institutes of Health 2006. Available at:
http://www.nimh.nih.gov/healthinformation/adhdmenu.cfm. Accessed June
15, 2006.
Nogovitsina OR, Levitina EV. Diagnostic value of examination of the
magnesium homeostasis in children with attention deficit syndrome with
hyperactivity [in Russian]. Klin Lab Diagn. 2005 May;(5):17-9.
Nogovitsina OR, Levitina EV. Effect of MAGNE-B6 on the clinical and
biochemical manifestations of the syndrome of attention deficit and
hyperactivity in children [in Russian]. Eksp Klin Farmakol. 2006a
Jan-Feb;69(1):74-7.
Nogovitsina OR, Levitina EV. Neurological aspect of clinical
symptoms, pathophysiology and correction in attention deficit
hyperactivity disorder [in Russian]. Zh Nevrol Psikhiatr Im S S
Korsakova. 2006b;106(2):17-20.
Overmeyer S, Bullmore ET, et al. Distributed grey and white matter
deficits in hyperkinetic disorder: MRI evidence for anatomical
abnormality in an attentional network. Psychol Med. 2001
Nov;31(8):1425-35.
Paule MG, Rowland AS, et al. Attention deficit/hyperactivity
disorder: characteristics, interventions and models. Neurotoxicol
Teratol. 2000 Sep;22(5):631-51.
Pliszka SR. Neuroimaging and ADHD. ADHD Report. 2002;10:1016.
Ponce AG, Rodriguez-Jimenez CR, et al. Attention-deficit
hyperactivity disorder and vulnerability to the development of
alcoholism: use of the Wender-Utah Rating Scale for retrospective
diagnosis of ADHD in the childhood of alcoholic patients [in Spanish].
Actas Esp Psiquiatr. 2000 Nov;28(6):357-66.
Rice DC. Parallels between attention deficit hyperactivity disorder
and behavioral deficits produced by neurotoxic exposure in monkeys.
Environ Health Perspect. 2000 Jun;108(suppl 3):405-8.
Rowe KS, Rowe KJ. Synthetic food coloring and behavior: a dose
response effect in a double-blind, placebo-controlled,
repeated-measures study. J Pediatr. 1994 Nov;125(pt 1):691-8.
Schnoll R, Burshteyn D, et al. Nutrition in the treatment of
attention-deficit hyperactivity disorder: a neglected but important
aspect. Appl Psychophysiol Biofeedback. 2003 Mar;28(1):63-75.
Stevens L, Zhang W, et al. EFA supplementation in children with
inattention, hyperactivity, and other disruptive behaviors. Lipids.
2003 Oct;38(10):1007-21.
Strous RD, Spivak B, et al. Analysis of neurosteroid levels in
attention deficit hyperactivity disorder. Int J Neuropsychopharmacol.
2001 Sep;4(3):259-64.
Sunohara GA, Roberts W, et al. Linkage of the dopamine D4 receptor
gene and attention-deficit/hyperactivity disorder. J Am Acad Child
Adolesc Psychiatry. 2000 Dec;39(12):1537-42.
Tantillo M, Kesick CM, et al. The effects of exercise on children
with attention-deficit hyperactivity disorder. Med Sci Sports Exerc.
2002 Feb;34(2):203-12.
Taylor FB, Russo J. Efficacy of modafinil compared to
dextroamphetamine for the treatment of attention deficit hyperactivity
disorder in adults. J Child Adolesc Psychopharmacol. 2000;10(4):311-20.
Warner-Rogers J, Taylor A, et al. Inattentive behavior in childhood:
epidemiology and implications for development. J Learn Disabil. 2000
Nov;33(6):520-36.
Weiler MD, Bernstein JH, et al. Processing speed in children with
attention deficit/hyperactivity disorder, inattentive type.
Neuropsychol Dev Cogn C Child Neuropsychol. 2000 Sep;6(3):218-34.
Weiss MD, Wasdell MB, et al. Sleep hygiene and melatonin treatment
for children and adolescents with ADHD and initial insomnia. J Am Acad
Child Adolesc Psychiatry. 2006 May;45(5):512-9.
White BP, Becker-Blease KA, et al. Stimulant medication use, misuse,
and abuse in an undergraduate and graduate student sample. J Am Coll
Health. 2006 Mar-Apr;54(5):261-8.
Wilens TE, Waxmonasky J, et al. An open trial of adjunctive
donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc
Psychopharmacol. 2005 Dec;15(6):947-55.
Young GS, Conquer JA, et al. Effect of randomized supplementation
with high dose olive, flax or fish oil on serum phospholipid fatty acid
levels in adults with attention deficit hyperactivity disorder. Reprod
Nutr Dev. 2005 Sep-Oct;45(5):549-58.
Print
PDF
Email
View Health Concern
